SAFETY AND EFFICACY OF ROMIPLOSTIM IN OVER 200 CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)

被引：0
|
作者：
Tarantino, Michael [1 ]
Despotovic, Jenny [1 ]
Roy, John [1 ]
Grainger, John [1 ]
Cooper, Nichola [1 ]
Beam, Donald [1 ]
Raj, Ashok [1 ]
Maschan, Alexey [1 ]
Kim, June [1 ]
Eisen, Melissa [1 ]
机构：
[1] Univ Illinois, Coll Med Peoria, Peoria, IL USA
来源：
PEDIATRIC BLOOD & CANCER | 2019年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
624
引用
收藏
页数：2
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF SUCCESSFUL TREATMENT IMMUNE THROMBOCYTOPENIC PURPURA (ITP) WITH THE THROMBOPOIETIN-MIMETIC ROMIPLOSTIM
    Mantzourani, M.
    Katsandris, A.
    Ntziora, F.
    Tsifis, J.
    Vaiopoulos, G.
    Meletis, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 751 - 751
  • [42] Treatment of chronic immune thrombocytopenia in children with romiplostim
    Chaturvedi, Shruti
    McCrae, Keith R.
    LANCET, 2016, 388 (10039): : 4 - 6
  • [43] Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
    Kuter, David J.
    Bussel, James B.
    Newland, Adrian
    Baker, Ross I.
    Lyons, Roger M.
    Wasser, Jeffrey
    Viallard, Jean-Francois
    Macik, Gail
    Rummel, Mathias
    Nie, Kun
    Jun, Susie
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (03) : 411 - 423
  • [44] Splenectomy, rituximab and romiplostim in chronic ITP: efficacy and safety profile
    Mingot, M. E.
    Diaz-Canales, D.
    Prieto-Bonilla, M. R.
    Contento, A.
    Bailen-Garcia, A.
    Heiniger-Mazo, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 329 - 329
  • [45] COST EFFECTIVENESS OF ROMIPLOSTIM FOR THE TREATMENT OF IMMUNE THROMBOCYTOPENIA (ITP) PATIENTS IN THE CZECH REPUBLIC
    Brezina, T.
    Klimes, J.
    Dolezal, T.
    Maskova, H.
    Campioni, M.
    Kutikova, L.
    VALUE IN HEALTH, 2014, 17 (07) : A533 - A533
  • [46] A PHARMACOECONOMIC EVALUATION OF ROMIPLOSTIM (NPLATE®) FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) IN MEXICO
    Arocho, R.
    Northridge, K.
    Rivera Hurtado, R.
    Garcia Chavez, J.
    VALUE IN HEALTH, 2011, 14 (03) : A62 - A62
  • [47] Updated results from the single-arm, open-label, long-term efficacy and safety study of subcutaneous (SC) romiplostim in children with immune thrombocytopenia (ITP)
    Grainger, J.
    Bussel, J.
    Tarantino, M.
    Cooper, N.
    Beam, D.
    Despotovic, J.
    Maschan, A.
    Wang, K.
    Bowers, C.
    Eisen, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 41 - 41
  • [48] Safety and efficacy of romiplostim in patients with eltrombo-pag-resistant or -intolerant immune thrombocytopenia
    Tsukamoto, Shokichi
    Nakaseko, Chiaki
    Takeuchi, Masahiro
    Kumagai, Kyoya
    Komatsu, Tsunehiko
    Tanaka, Hiroaki
    Hara, Satoru
    Koizumi, Masayuki
    Imai, Hidenori
    Yokota, Akira
    Takeuchi, Masami
    Inokuchi, Koiti
    Matsuura, Yasuhiro
    Aotsuka, Nobuyuki
    Wakita, Hisashi
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (02) : 286 - 289
  • [49] Updated Results from the Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
    Grainger, John
    Bussel, James B.
    Tarantino, Michael D.
    Cooper, Nichola
    Beam, Donald
    Despotovic, Jenny M.
    Maschan, Alexey A.
    Wang, Kejia
    Eisen, Melissa Jeanne
    Bowers, Charles
    BLOOD, 2019, 134
  • [50] Long-Term Use of the Thrombopoietin-Mimetic Romiplostim in Children With Severe Chronic Immune Thrombocytopenia (ITP)
    Bussel, James B.
    Hsieh, Loan
    Buchanan, George R.
    Stine, Kimo
    Kalpatthi, Ram
    Gnarra, David J.
    Ho, Richard H.
    Nie, Kun
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2015, 62 (02) : 208 - 213
12345